Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

2.

Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M.

Cell Growth Differ. 1996 Feb;7(2):213-21.

3.

Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.

Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, Tsang ML.

J Biol Chem. 1996 Feb 9;271(6):3154-62.

4.
5.
6.

Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.

Viglietto G, Romano A, Manzo G, Chiappetta G, Paoletti I, Califano D, Galati MG, Mauriello V, Bruni P, Lago CT, Fusco A, Persico MG.

Oncogene. 1997 Nov 27;15(22):2687-98.

7.

Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.

Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS.

Placenta. 1997 Nov;18(8):657-65.

PMID:
9364601
8.
9.
10.

Computer modelling of the receptor-binding domains of VEGF and PIGF.

Walsh TP, Grant GH.

Protein Eng. 1997 Apr;10(4):389-98.

PMID:
9194163
11.
12.

Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells.

Barleon B, Hauser S, Schöllmann C, Weindel K, Marmé D, Yayon A, Weich HA.

J Cell Biochem. 1994 Jan;54(1):56-66.

PMID:
8126087
13.

Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH.

J Biol Chem. 1994 Oct 28;269(43):26988-95.

14.

Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.

Gengrinovitch S, Greenberg SM, Cohen T, Gitay-Goren H, Rockwell P, Maione TE, Levi BZ, Neufeld G.

J Biol Chem. 1995 Jun 23;270(25):15059-65.

15.

Characterization of the VEGF binding site on the Flt-1 receptor.

Herley MT, Yu Y, Whitney RG, Sato JD.

Biochem Biophys Res Commun. 1999 Sep 7;262(3):731-8.

PMID:
10471394
16.

Characterization of a soluble vascular endothelial growth factor receptor-immunoglobulin chimera.

Kaplan JB, Sridharan L, Zaccardi JA, Dougher-Vermazen M, Terman BI.

Growth Factors. 1997;14(4):243-56.

PMID:
9386989
17.

A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.

Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M.

Oncogene. 1995 Jan 5;10(1):135-47.

PMID:
7824266
18.

Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.

Barleon B, Totzke F, Herzog C, Blanke S, Kremmer E, Siemeister G, Marmé D, Martiny-Baron G.

J Biol Chem. 1997 Apr 18;272(16):10382-8.

20.

Identification of a heparin binding peptide on the extracellular domain of the KDR VEGF receptor.

Dougher AM, Wasserstrom H, Torley L, Shridaran L, Westdock P, Hileman RE, Fromm JR, Anderberg R, Lyman S, Linhardt RJ, Kaplan J, Terman BI.

Growth Factors. 1997;14(4):257-68.

PMID:
9386990

Supplemental Content

Support Center